Helmut Baumgartner
Institution:
Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Director, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Germany
since 2007 – Full Professor (Cardiology/Adult Congenital Heart Disease), University of Muenster, Germany
Previous Appointments
1993 – 2007 Staff cardiologist, Dept. of Cardiology, Medical University – Vienna General Hospital
1993 – 2007 Professor of Medicine / Cardiology, Medical University of Vienna
1993 – 2007 Director, Adult Congenital Heart Disease and Acquired Valvular Heart Disease Program, Medical University of Vienna
1993 – 2007 Director, Research Program on Adult Congenital Heart Disease and Acquired Valvular Heart Disease, Medical University of Vienna
1993 – 2007 Director, In-Vitro Echocardiography Research Laboratory
1993 – 2001 Director, Echocardiography Laboratory, Dept. of Cardiology, Medical University of Vienna
1992 – 1993 Staff cardiologist and Director, Echocardiography Laboratory, 2nd Department of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Postgraduate Training
1981 – 1983 Internship, Krankenhaus der Barmherzigen Schwestern , Linz and St. Pölten General Hospital, Austria
1994 – 1989 Residency/Fellowship, Internal Medicine; 1st and 2nd Dept. of Internal Medicine, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
1989 – 1990 Research Fellowship, Division of Cardiology, Cedars-Sinai Medical Center, University of California at Los Angeles, Los Angeles, USA
1990 – 1991 Clinical Fellowship in Cardiology; 2nd Dept. of Internal Medicine / Cardiology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria
Research Activities
Clinical and basic research in the area of valvular heart disease and congenital heart disease
Clinical and experimental research in echocardiography
Catheter intervention in congenital and acquired valvular heart disease Myocardial viability
More than 250 publications, of these more than 150 papers in peer-reviewed journals
Medical Societies / Fellowships / Journals (selected)
Austrian Society of Cardiology: Chairman of the working group on adult congenital heart disease; President of the Society 2005-2007
European Society of Cardiology: Board member 2006-2008; Nucleus member of the working group on grown-up congenital heart disease, co-chairman 2004-2006, chairman 2006–2008, past-chairman 2008-2010, Chairman, TF Practice guidelines on the management of grown-up congenital heart disease, Task forces and committees (Practice guidelines on the management of valvular heart disease, Education committee, Accreditation committee), Clinical Practice Guidelines Committee (2010-2014),Congress Programme Committee (2010-2014)
Michael Böhm
Institution:
University Saarland, Homburg/Saar, Germany
1977 – 1984 Medical School; Medical School of Hannover
1984 – 1986 Pharmacology; University of Hamburg
1986 – 1993 Internal Medicine and Cardiology; University of Munich
1993 – 2000 Professor of Cardiology; University of Cologne
2000 Professor of Internal Medicine and Cardiology; University of the Saarland, Homburg/Saar
Scientific Career
1980 – 1983 Head of Department of Internal Medicine, Pulmonology and Critical Care Medicine Thoraxklinik Heidelberg
Speciality certification:
1980 – 1983 Training in pharmacology in the Division of Biochemical Pharmacology at the Medical University of Hannover
1984 Doctoral thesis in the Medical Faculty at the Medical University of Hannover (Dept. Biochemical Pharmacol)
1984 – 1986 Resident of the Division of General Pharmacology at the University Hospital of Eppendorf of the University of Hamburg
1986 – 1993 Resident at the Medizinische Klinik I, Klinikum Großhadern, Department of Internal Medicine and Cardiology, Ludwig-Maximilians-Universität München
1992 Certification of Internal Medicine
1993 Assistant Professor of Cardiology at the Klinik III für Innere Medizin, University of Cologne
1993 Certification of Cardiology
1994 Heisenberg-Programm of the Deutsche Forschungsgemeinschaft (DFG)
1995 – 2000 C3-Professorship for Internal Medicine and Cardiology, Innere Medizin III, University of the Cologne
2000 C4-Professorship and Director for Internal Medicine, Cardiology, Angiology and Intensiv Care Medicine, University of the Saarland, Homburg/Saar
2007 President Elect of the German Cardiac Society
2009 President of the German Cardiac Society
2010 Board member and Chairman of the Scientific Program Committee of the European Society of Cardiology (ESC)
2012 Honorary member and medal of merit of the Hungaria Society of Cardiology
2012 Order and Cross of Merit of the Federal Republic of Germany
Scientific Journals
Chief Editor: Clinical Research in Cardiology
Consulting Editor: Basic Research in Cardiology
Editorial Board: Cardiovascular Research, Cardiovascular Drugs and Therapy, European Heart Journal
Reviewer: Circulation, Circulation Research, Hypertension, Lancet, European Journal of Heart Failure, European Heart Journal and others
Trial Experience
National Coordinator: COMET, CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL
Executive Board: SHIFTDSMBRECORD
Steering Committee: CORONA, ONTARGET, TRANSCEND, SENIORS, ESSENTIAL, ASTRONAUT
Principal Investigator: OPTILINK, EDIfY
Marianne Brodmann
Institution:
Medical University Graz, Austria
Marianne Brodmann is an Austrian angiologist. She has graduated from the University of Graz. She is a board-certified specialist in Internal Medicine and Angiology. Marianne Brodmann is the head of the Division of Angiology at the Internal Medicine Department of the Medical University Graz, Austria. Her main interests are endovascular interventions in PAD, as well as education and training of young angiologists. Marianne Brodmann is Past President of the European Society of Vascular Medicine, Past Chairperson of the ESC Working Group of PAD and Past President of the Austrian Society of Angiology.
Victoria Delgado Garcia
Institution:
University Hospital Germans Trias i Pujol and Centre of Competitive Medicine and Bioimaging in Badalona, Spain
Dr. Victoria Delgado is currently the head of the cardiovascular imaging department of the Heart Institute at the University Hospital Germans Trias i Pujol and scientific director of the Centre of Competitive Medicine and Bioimaging in Badalona, Spain. She graduated in medical school at the University of Barcelona (Spain), accomplished her training in Cardiology at the Hospital Clinic in Barcelona (Spain) and followed a 3-year fellowship at the Leiden University Medical Center (The Netherlands) where she was appointed as cardiologist with expertise on multimodality imaging from 2010 till 2021. She obtained her PhD degree cum laude in 2010 at the Leiden University with the thesis entitled Novel Cardiac Imaging Technologies: Implications in Clinical Decision Making.
She has more than 800 per-reviewed publications, and an H-factor of 90. She has contributed to more than 20 textbooks, including the worldwide recognized landmark book Hurst’s The Heart, 15th edition. She has been co-promotor of 17 PhD students and currently supervises 6 PhD fellows.
She has been Associate Editor of the Journal of American Society of Echocardiography and she is currently Senior Editor of Circulation. She has been very much involved at the European Society of Cardiology, in several task force of guidelines, in the Clinical Practice Guidelines Committee, European Observational Registry Programme and ESC Congress programme committee. She has been councilor of the ESC Board and is currently the President-elect of the European Association of Cardiovascular Imaging.
Massimo Federici
Institution:
Policlinico Tor Vergata Hospital, Rome, Italy
Massimo Federici, MD, is Professor of Internal Medicine, Director of Center for Atherosclerosis at Policlinico Tor Vergata Hospital. After specialty in Endocrinology and Metabolic Diseases and research fellowship at Joslin Diabetes Center (Harvard Medical School), in 2000 he started an academic (clinical activity and translational research) career dedicated to investigate the molecular basis of aging-related diseases such as diabetes and atherosclerosis. Since 2002 he coordinates the Laboratory of Molecular Medicine in the Department of Systems Medicine at University of Rome Tor Vergata, funded by EU (FP7, H2020, IMI2, EU Next Generation), Italian Ministry of University, Italian Ministry of Health, Telethon, AIRC, Juvenile Diabetes Research Foundation (JDRF), European Diabetes Foundation (EFSD), Fondazione Roma and other funding agencies.
Since 2018 he is Professor and Chair in Internal Medicine at University of Rome Tor Vergata. He is co-chairman of the ESC 2023 Guidelines for the management of cardiovascular disease in patients with diabetes.
Pablo Garcia-Pavia
Institution:
Hospital Universitario Puerta de Hierro, Madrid, Spain
Dr García-Pavia is the director of the Inherited Cardiac Diseases and Heart Failure Unit at the Department of Cardiology of Hospital Universitario Puerta de Hierro in Madrid, Spain. The Unit is designated as national reference unit (CSUR) for inherited cardiovascular diseases by the Spanish Ministry of Health and also acts as a European reference center for rare cardiovascular diseases (ERN). He is also Research Professor at the Spanish Cardiovascular Research Institute (CNIC)
His areas of research include heart failure, amyloidosis and cardiomyopathies. After finishing his training in Cardiology in Madrid, Dr Garcia-Pavia completed a clinical research fellowship at the Inherited Cardiovascular Diseases Unit at The Heart Hospital (University College of London) in London, UK. Previously he had undertaken short stays as research fellow in basic research labs focused in genetics at the University of Chicago, Madrid Complutense University and Madrid Autonoma University .
Dr Garcia-Pavia is the leader of the 2021 ESC position paper on diagnosis and treatment of cardiac amyloidosis and serves in the steering committee of several ongoing clinical trials in TTR cardiac amyloidosis and genetic cardiomyopathies. He is also former member of ESC Council on Basic Research, former member of the Nucleus of ESC working group on myocardial and pericardial diseases, and former president of Spanish Society of Cardiology’s working group on inherited cardiac diseases. He has published >220 articles in peer-reviewed journals including The New England Journal of Medicine, European Heart Journal, J Am Coll Cardiol, Circulation, Nature Communications, Nature Medicine and The Lancet.
Petr Kala
Institution:
University Hospital Brno, Czech Republic
Dr. Kala graduated in 1990, he co-founded the Interventional Cardiology Programme in 1994, Structural Heart Interventions in 2003 and TAVI in 2009.
For many years he has been taking part in the Board of the Working Group and Czech Association of Interventional Cardiology and served as its President/Vice-President 2006 – 2012 and from 2020.
He has been a Fellow of the European Society of Cardiology (F.E.S.C) and Fellow of the Society of Cardiac Angiography and Intervention (F.S.C.A.I), member of the EAPCI Board Committees from 2007 and the EAPCI Board member and Chairman of the Stent for Life Initiative 2012-2016 and member of the International Society for Heart Research (ISHR) and American Heart Association (AHA).
Dr. Kala has been involved in the medical research focused on the interventional and acute cardiology and structural interventions. His publication activity comprise more than 150 peer-reviewed articles, two books and number of book chapters with H-index 33.
In 2019 he founded KardioSIM – High-tech Simulation training centre in interventional cardiology, in 2020 3D printing lab and in 2021 Innovation Centre.
Andre Keren
Institution:
Heart Failure and Heart Muscle Disease Center, Hadassah University Hospital, Jerusalem, Israel
Andre Keren is Professor Emeritus of Medicine (Cardiology) at Hadassah-Hebrew University School of Medicine Professional Activities
1982-1984 Post Doctoral Fellow, Cardiology Division, Department of Medicine, Stanford University Hospital, Stanford, California, USA.
1993-1994 Visiting Associate Professor, Department of Medicine, Division of Cardiology, Stanford University Hospital, Stanford, California, USA. 1997-2001 Chairman of the Working Group on Myocardial and Pericardial Diseases of the Israeli Society of Cardiology
1999 – 2006 Director, Department of Cardiology, Bikur Cholim Hospital, Jerusalem, affiliated with the Hebrew University – Hadassah Medical School, Jerusalem, Israel
1999-2006 Chairman of the Jerusalem Heart Chapter of the Israel Heart Society
2001- 2004 Chairman of the National Board of Examinations in Cardiology 2006 Visiting Professor, University College of London Hospitals, London, United Kingdom
2006 – 2008 Member of the Task Force of the European Society of Cardiologyfor Guidelines of “Diagnosis and Treatment of Acute and Chronic Heart Failure 2008”.
2006- 2008 Chairman of the Working Group of Myocardial and Pericardial Diseases, of the European Society of Cardiology
2006 – 2015 Director, Heart Failure and Heart Muscle Disease Center, Hadassah-Hebrew University Hospital, Jerusalem, Israel
2014- Coordinator of National Society Meetings in the Congress Program Committee of the European Society of Cardiology
2013- Member, National Committee of Medical Accreditation of the Health Ministry 2013 – Official representative of the Israel Heart Society in the Israeli Ministry of Health Committee for revision of the regulations of athletes’ screening
2015 – Member of the National Cardiology Advisory Board of the Ministry of Health 2015- Senior Cardiologist, Hadassah-Hebrew University Hospital, Dept of Cardiology
2015 – Director of Heart Failure Services, Clalit HMO, Jerusalem District
2015 – Director of Heart Institute, Assuta Hashalom Tel Aviv, Assuta Hospitals
Fellowships: Fellow of the European Society of Cardiology, American College of Cardiology, American Heart Association Council on Cardiovascular Sciences, Israel Heart Society, International Society of Cardiovascular Ultrasound, Honorary Member of the Romanian Society of Cardiology
Publications Over 170 published papers in peer-reviewed journals
Irene Marthe Lang
Institution:
Medical University of Vienna, Austria
Professor Irene Lang is Head of Cardiac Catheterization Laboratory, Head of the Pulmonary Hypertension Outpatient Clinic at the Medical University of Vienna and Deputy Director of the Clinical Department of Cardiology.
Professor Lang’s basic and clinical research include Thrombosis and Vascular Biology, Pulmonary Hypertension and Coronary Artery Disease and ACS. Her main therapeutic areas are Stable Ischemic Heart Disease, Myocardial Infarction, Pulmonary Hypertension, Thrombosis, Vascular Biology, and Heart Failure.
Felix Mahfoud
Institution:
University Hospital Basel, Switzerland
Felix Mahfoud is professor of medicine and deputy director of the Department for Internal Medicine and Cardiology at Saarland University Hospital and Visiting Professor at Harvard-MIT, Biomedical Engineering, Boston, MA. From June 1st, Felix Mahfoud will serve as Head of Department and Professor of Cardiology at University Basel, Switzerland. Professor Mahfoud holds board certifications in internal medicine, cardiology, intensive care medicine, emergency medicine, and hypertension. He is member of several editorial boards and serves as Secretary of the Council on Hypertension of the European Society of Cardiology (ESC)‚ PCR Board of Director and program committee member (topic coordinator hypertension) of the ESC congress 2023 & 2024. He has authored more than 460 articles in peer reviewed journals and was writing committee member of the 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, the 2018 ESC/ESH Guidelines for the management of arterial hypertension, and the 2023 ESH Guidelines for the management of arterial hypertension.
Christian Sticherling
Institution:
Department of Cardiology of the University Hospital Basel, Switzerland
Christian Sticherling is professor of Cardiology, Head of Electrophysiology and Deputy Chief of the Department of Cardiology of the University Hospital Basel, Switzerland. He received his MD from the University of Heidelberg, Germany. He completed his training in cardiology at the University of Frankfurt and the Charité University Hospital in Berlin. For his fellowship in Invasive Electrophysiology he spent 2 years at the University of Michigan in Ann Arbor, MI.
Professor Sticherling is an active member of EHRA as well as of the ESC, serves in the editorial board of Europace, is past-president of the working group “Cardiac Pacing and Electrophysiology” of the Swiss Society of Cardiology and the acting president of the Swiss Rhythmology Foundation.
He authored more than 330 peer-reviewed articles and was in the writing committee of the 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. His research interests include risk stratification of sudden cardiac death, invasive therapy of atrial fibrillation and the role of wearables for the diagnosis and monitoring of cardiac arrhythmias.
Arian Sultan
Institution:
ASKLEPIOS Clinic St. Georg, Hamburg, Germany
Professor of Cardiology and Internal Medicine Arian Sultan, M.D., FEHRA, Head of Electrophysiology, Heart Center St. Georg Hamburg, Department of Cardiology and Internal Intensive Care Medicine, ASKLEPIOS Clinic St. Georg, Germany.
Med School 1997-2004 University of Hamburg, Germany, USA, Chile. Residency, Fellowship and Board Certification at University Heart Center Hamburg-Eppendorf 2004 – 2014.
In 2014 senior consultant at the University Heart Center Cologne.
2022 – 2025 Co-Head of the EP-Department at the University Heart Center Cologne.
Since 2025 Head of Electrophysiology at the Heart Center St. Georg Hamburg, ASKLEPIOS Clinic St. Georg
2019-2021 DAS-CAM EHRA Class.
2020-2022 ESC Alumni Task Force Member.
2022-2024 EHRA SIC Committee Member.
Co-leading the women in EP initiative Germany, Swiss, Austria. Reviewer for international journals (e.g. EHJ, JACCEP, JCE, IJC), Since 2021 FEHRA (Fellow of European Society of Cardiology). Course director for the preparatory allied professional course EHRA 2022. Course director for the preparatory EHRA Exam course EHRA 202.
